{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T05:18:04Z","timestamp":1740028684363,"version":"3.37.3"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,19]]},"DOI":"10.7759\/cureus.79307","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T17:56:01Z","timestamp":1739987761000},"source":"Crossref","is-referenced-by-count":0,"title":["Impact of Low Hepatitis Delta Virus Screening Rates on the Accurate Estimation of Seroprevalence in Florida: A Retrospective Observational Study"],"prefix":"10.7759","author":[{"given":"Sean-Patrick A","family":"Prince","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sirisha","family":"Gaddipati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yalda","family":"Zarnegarnia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia Denise D","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.18.12.997","article-title":"Immunofluorescence detection of new antigen-antibody system (delta\/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers","volume":"18","author":"Rizzetto M","year":"1977","unstructured":"Rizzetto M, Canese MG, Aric\u00f2 S, Crivelli O, Trepo C, Bonino F, Verme G. Immunofluorescence detection of new antigen-antibody system (delta\/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut. 1977, 18:997-1003. 10.1136\/gut.18.12.997","journal-title":"Gut"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61931-9","article-title":"Hepatitis delta virus","volume":"378","author":"Hughes SA","year":"2011","unstructured":"Hughes SA, Wedemeyer H, Harrison PM. Hepatitis delta virus. Lancet. 2011, 378:73-85. 10.1016\/S0140-6736(10)61931-9","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.04.008","article-title":"The global prevalence of hepatitis D virus infection: systematic review and meta-analysis","volume":"73","author":"Stockdale AJ","year":"2020","unstructured":"Stockdale AJ, Kreuels B, Henrion MY, et al.. The global prevalence of hepatitis D virus infection: systematic review and meta-analysis. J Hepatol. 2020, 73:523-32. 10.1016\/j.jhep.2020.04.008","journal-title":"J Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-023-07960-y","article-title":"Diagnosis and management of hepatitis delta virus infection","volume":"68","author":"Pan C","year":"2023","unstructured":"Pan C, Gish R, Jacobson IM, Hu KQ, Wedemeyer H, Martin P. Diagnosis and management of hepatitis delta virus infection. Dig Dis Sci. 2023, 68:3237-48. 10.1007\/s10620-023-07960-y","journal-title":"Dig Dis Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.05.001","article-title":"EASL Clinical Practice Guidelines on hepatitis delta virus","volume":"79","author":"European Association for the Study of the Liver","year":"2023","unstructured":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines on hepatitis delta virus. J Hepatol. 2023, 79:433-60. 10.1016\/j.jhep.2023.05.001","journal-title":"J Hepatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault NA","year":"2018","unstructured":"Terrault NA, Lok AS, McMahon BJ, et al.. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018, 67:1560-99. 10.1002\/hep.29800","journal-title":"Hepatology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2212151","article-title":"Hepatitis D virus infection","volume":"389","author":"Asselah T","year":"2023","unstructured":"Asselah T, Rizzetto M. Hepatitis D virus infection. N Engl J Med. 2023, 389:58-70. 10.1056\/NEJMra2212151","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000687","article-title":"Prevalence and characteristics of hepatitis delta virus infection in patients with hepatitis B in the United States: an analysis of the All-Payer Claims Database","volume":"79","author":"Gish RG","year":"2024","unstructured":"Gish RG, Jacobson IM, Lim JK, et al.. Prevalence and characteristics of hepatitis delta virus infection in patients with hepatitis B in the United States: an analysis of the All-Payer Claims Database. Hepatology. 2024, 79:1117-28. 10.1097\/HEP.0000000000000687","journal-title":"Hepatology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz001","article-title":"Prevalence of hepatitis B and hepatitis D virus infections in the United States, 2011-2016","volume":"69","author":"Patel EU","year":"2019","unstructured":"Patel EU, Thio CL, Boon D, Thomas DL, Tobian AA. Prevalence of hepatitis B and hepatitis D virus infections in the United States, 2011-2016. Clin Infect Dis. 2019, 69:709-12. 10.1093\/cid\/ciz001","journal-title":"Clin Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000001947","article-title":"Low performance of hepatitis delta virus testing among 2 national cohorts of chronic hepatitis B patients in the United States","volume":"117","author":"Wong RJ","year":"2022","unstructured":"Wong RJ, Kaufman HW, Niles JK, et al.. Low performance of hepatitis delta virus testing among 2 national cohorts of chronic hepatitis B patients in the United States. Am J Gastroenterol. 2022, 117:2067-70. 10.14309\/ajg.0000000000001947","journal-title":"Am J Gastroenterol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2022.107136","article-title":"Hepatitis C virus (HCV) seroprevalence, RNA detection, and genotype distribution across Florida, 2015-2018","volume":"161","author":"Dickey BL","year":"2022","unstructured":"Dickey BL, Coghill AE, Rathwell JA, et al.. Hepatitis C virus (HCV) seroprevalence, RNA detection, and genotype distribution across Florida, 2015-2018. Prev Med. 2022, 161:107136. 10.1016\/j.ypmed.2022.107136","journal-title":"Prev Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000028316","article-title":"Do patients at high risk for Hepatitis C receive recommended testing? A retrospective cohort study of statewide Medicaid claims linked with OneFlorida clinical data","volume":"100","author":"Mkuu RS","year":"2021","unstructured":"Mkuu RS, Shenkman EA, Muller KE, et al.. Do patients at high risk for Hepatitis C receive recommended testing? A retrospective cohort study of statewide Medicaid claims linked with OneFlorida clinical data. Medicine (Baltimore). 2021, 100:e28316. 10.1097\/MD.0000000000028316","journal-title":"Medicine (Baltimore)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2020.106222","article-title":"HCV testing: order and completion rates among baby boomers obtaining care from seven health systems in Florida, 2015-2017","volume":"153","author":"Vadaparampil ST","year":"2021","unstructured":"Vadaparampil ST, Fuzzell LN, Rathwell J, et al.. HCV testing: order and completion rates among baby boomers obtaining care from seven health systems in Florida, 2015-2017. Prev Med. 2021, 153:106222. 10.1016\/j.ypmed.2020.106222","journal-title":"Prev Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.04.025","article-title":"Delta hepatitis within the Veterans Affairs medical system in the United States: prevalence, risk factors, and outcomes","volume":"63","author":"Kushner T","year":"2015","unstructured":"Kushner T, Serper M, Kaplan DE. Delta hepatitis within the Veterans Affairs medical system in the United States: prevalence, risk factors, and outcomes. J Hepatol. 2015, 63:586-92. 10.1016\/j.jhep.2015.04.025","journal-title":"J Hepatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15921","article-title":"Estimating the prevalence of hepatitis delta virus infection among adults in the United States: a meta-analysis","volume":"44","author":"Wong RJ","year":"2024","unstructured":"Wong RJ, Brosgart C, Wong SS, et al.. Estimating the prevalence of hepatitis delta virus infection among adults in the United States: a meta-analysis. Liver Int. 2024, 44:1715-34. 10.1111\/liv.15921","journal-title":"Liver Int"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13779","article-title":"The Delta Delta: gaps in screening and patient assessment for hepatitis D virus infection","volume":"30","author":"Nathani R","year":"2023","unstructured":"Nathani R, Leibowitz R, Giri D, et al.. The Delta Delta: gaps in screening and patient assessment for hepatitis D virus infection. J Viral Hepat. 2023, 30:195-200. 10.1111\/jvh.13779","journal-title":"J Viral Hepat"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz633","article-title":"Estimating the global prevalence, disease progression, and clinical outcome of hepatitis delta virus infection","volume":"221","author":"Miao Z","year":"2020","unstructured":"Miao Z, Zhang S, Ou X, et al.. Estimating the global prevalence, disease progression, and clinical outcome of hepatitis delta virus infection. J Infect Dis. 2020, 221:1677-87. 10.1093\/infdis\/jiz633","journal-title":"J Infect Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae076","article-title":"Hepatitis delta virus reporting requirements in the United States and territories: a systematic review","volume":"11","author":"Assadi-Rad M","year":"2024","unstructured":"Assadi-Rad M, Acosta BE, Hesterman MC, et al.. Hepatitis delta virus reporting requirements in the United States and territories: a systematic review. Open Forum Infect Dis. 2024, 11:ofae076. 10.1093\/ofid\/ofae076","journal-title":"Open Forum Infect Dis"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000002810","article-title":"Multiple barriers impede screening for hepatitis delta: an Internet-based survey of healthcare providers","volume":"119","author":"Rao S","year":"2024","unstructured":"Rao S, Qazi S, Lee D, Molliner C, Martin P, Jones PD. Multiple barriers impede screening for hepatitis delta: an Internet-based survey of healthcare providers. Am J Gastroenterol. 2024, 119:2126-9. 10.14309\/ajg.0000000000002810","journal-title":"Am J Gastroenterol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/v13101912","article-title":"Hepatitis D review: challenges for the resource-poor setting","volume":"13","author":"Lee AU","year":"2021","unstructured":"Lee AU, Lee C. Hepatitis D review: challenges for the resource-poor setting. Viruses. 2021, 13:10.3390\/v13101912","journal-title":"Viruses"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.23242","article-title":"Hepatitis D: a review","volume":"330","author":"Negro F","year":"2023","unstructured":"Negro F, Lok AS. Hepatitis D: a review. JAMA. 2023, 330:2376-87. 10.1001\/jama.2023.23242","journal-title":"JAMA"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.12217","article-title":"Coinfection with hepatitis B and D: epidemiology, prevalence and disease in patients in Northern California","volume":"28","author":"Gish RG","year":"2013","unstructured":"Gish RG, Yi DH, Kane S, et al.. Coinfection with hepatitis B and D: epidemiology, prevalence and disease in patients in Northern California. J Gastroenterol Hepatol. 2013, 28:1521-5. 10.1111\/jgh.12217","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/325749-impact-of-low-hepatitis-delta-virus-screening-rates-on-the-accurate-estimation-of-seroprevalence-in-florida-a-retrospective-observational-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T17:56:02Z","timestamp":1739987762000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/325749-impact-of-low-hepatitis-delta-virus-screening-rates-on-the-accurate-estimation-of-seroprevalence-in-florida-a-retrospective-observational-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,19]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.79307","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,19]]}}}